Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Wilms tumor
Results 1-25 of 25 for your search:
Start Over
Combination Chemotherapy and Surgery in Treating Young Patients with Wilms Tumor
Phase: Phase III
Type: Supportive care, Treatment
Age: Under 30 at initial diagnosis
Trial IDs: AREN0534, NCI-2011-01953, CDR0000649716, COG-AREN0534, NCT00945009
Combination Chemotherapy and Fixed or Flexible Administration of Filgrastim in Treating Younger Patients With Cancer
Phase: Phase III
Type: Treatment
Age: 1 to 25
Trial IDs: 2013-062, NCI-2013-02001, NCT01987596
T-cell Depleted Stem Cell Boost in Improving Graft Function in Patients Who Have Undergone Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: 14-228, NCI-2015-00179, NCT02350777
Iodine I 131 Monoclonal Antibody 8H9 in Treating Patients with Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 and over
Trial IDs: 09-090, NCI-2010-01242, NCT01099644
Donor Hematopoietic Stem Cell Transplant in Treating Young Patients with Relapsed or Refractory Solid Tumors or Lymphomas
Phase: Phase I
Type: Treatment
Age: 2 to 21
Trial IDs: RADIANT, NCI-2012-00588, NCT01625351
Activated Natural Killer Cells with or without Recombinant Interleukin-15 in Treating Younger Patients with Refractory Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 to 25
Trial IDs: 13-C-0152, NCI-2013-01215, 09-25-0099, 130152, P9493_A06PAMDREVW01, 9493, NCT01875601
Simvastatin, Topotecan Hydrochloride, and Cyclophosphamide in Treating Younger Patients with Relapsed and/or Refractory Solid and CNS Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 29
Trial IDs: AFLACST1402, NCI-2015-00420, IRB00078790, NCT02390843
Gene Expression Profiles to Categorize Wilms Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Not specified
Trial IDs: AREN03B1, NCI-2009-00415, CDR0000349184, COG-AREN03B1, NCT00897637
Long-Term Effects of Cancer Therapy in Patients With Wilms' Tumor
Phase: No phase specified
Type: Natural history/Epidemiology
Age: 18 to 85
Trial IDs: COG-4941L, NCI-2009-00715, CDR0000069131, IRB00024842, Q9403, NCT00228696
Study of Kidney Tumors in Younger Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Age: Under 30
Trial IDs: AREN03B2, NCI-2009-00416, CDR0000459797, COG-AREN03B2, NCT00898365
Collecting and Storing Tissue From Young Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Age: 21 and under
Trial IDs: ABTR04B1, NCI-2009-00326, CDR0000478867, COG-ABTR04B1, NCT00898755
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Under 18
Trial IDs: AREN10B1, NCI-2011-02199, CDR0000657973, COG-AREN10B1, NCT01004783
Biomarkers in Tissue Samples from Patients With High-Risk Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 16 and under
Trial IDs: AREN10B2, NCI-2011-02230, CDR0000672402, COG-AREN10B2, NCT01118078
Biomarkers in Blood and Tumor Tissue Samples from Patients With Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Under 16
Trial IDs: AREN11B1, NCI-2011-02850, CDR0000696915, COG-AREN11B1, NCT01314391
Gene Mutation in Samples from Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Not specified
Trial IDs: COG-AREN11B2, NCI-2011-02854, CDR0000700282, AREN11B2, NCT01353300
Conditioning Therapy Followed by Stem Cell Transplant in Treating Patients with High Risk or Relapsed Solid or Central Nervous System Tumors
Phase: No phase specified
Type: Treatment
Age: 70 and under
Trial IDs: 2011OC057, NCI-2013-02265, 1107M02641, MT2011-09C, NCT01505569
Biomarkers in Tissue Samples from Younger Patients with Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Pediatric
Trial IDs: AREN12B2, NCI-2012-00686, CDR0000726713, COG-AREN12B2, NCT01542333
Biomarkers in Urine Samples From Patients With Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: No age specified
Trial IDs: AREN12B4, NCI-2012-00702, CDR0000727337, COG-AREN12B4, NCT01550393
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Under 21 at diagnosis
Trial IDs: AREN11B3, NCI-2012-00725, CDR0000730403, COG-AREN11B3, NCT01576198
Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 21 and under
Trial IDs: AREN12B6, NCI-2012-00726, CDR0000730596, COG-AREN12B6, NCT01576211
Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Pediatric
Trial IDs: AREN12B7, NCI-2012-01973, CDR0000734878, COG-AREN12B7, NCT01614808
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: Not specified
Trial IDs: AREN12B8, NCI-2012-01987, CDR0000736805, COG-AREN12B8, NCT01642095
Cyclophosphamide or Thalidomide after Stem Cell Transplant in Treating Younger Patients with Solid Tumors
Phase: No phase specified
Type: Treatment
Age: 5 to 21
Trial IDs: 201209088, NCI-2012-01541, NCT01661400
Molecular-Guided Therapy for Childhood Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 12 months to 21 years
Trial IDs: NMTRC009, NCI-2014-02270, NCT02162732
Start Over